NANETS: Despite Dose Reductions, Everolimus Promising in Advanced Pancreatic Neuroendocrine Tumors

NANETS: Despite Dose Reductions, Everolimus Promising in Advanced Pancreatic Neuroendocrine Tumors

Everolimus is a promising treatment option for pancreatic neuroendocrine tumors (pNETs), even though dose reductions are required for most patients.

NANETS: Intraoperative 5-FU May Reduce Need for Additional Surgeries in Midgut Neuroendocrine Tumors

NANETS: Intraoperative 5-FU May Reduce Need for Additional Surgeries in Midgut Neuroendocrine Tumors

Intraoperatively-placed 5-fluouracil (5-FU) chemotherapy at lymph node surgical dissection beds may lower the chance of necessary surgery.

NANETS: Pancreatic Neuroendocrine Tumors Harbor DNA Repair Gene Defects

NANETS: Pancreatic Neuroendocrine Tumors Harbor DNA Repair Gene Defects

Pancreatic neuroendocrine tumors (pNETs) harbor genetic mutations in DNA repair pathways that represent "strong candidates".

NANETS: Axitinib Yields "Promising" Progression-Free Survival for Advanced Carcinoid Tumors

NANETS: Axitinib Yields "Promising" Progression-Free Survival for Advanced Carcinoid Tumors

Axitinib could be an effective treatment option for unresectable and metastatic carcinoid tumors.

NANETS: Diarrhea Impacts Health-Related Quality of Life in Patients with Neuroendocrine Tumors

NANETS: Diarrhea Impacts Health-Related Quality of Life in Patients with Neuroendocrine Tumors

Diarrhea is associated with worse health-related quality of life in patients with neuroendocrine tumor (NET) symptoms.

NANETS: Hypermethylation Common in Small Intestinal Neuroendocrine Tumors

NANETS: Hypermethylation Common in Small Intestinal Neuroendocrine Tumors

Epigenetic signatures may help detect and differentiate small intestinal neuroendocrine tumors (SINETs) from other tumor types.

NANETS: Pancreastatin Predicts Survival in Patients with Neuroendocrine Tumors

NANETS: Pancreastatin Predicts Survival in Patients with Neuroendocrine Tumors

Higher pancreastatin associated with worse survival times in surgically treated small bowel (SBNET) and pancreatic neuroendocrine tumors (PNETs).

NANETS: Radical Resection of Pancreatic Neuroendocrine Tumors with Liver Mets Often Prolongs Survival

NANETS: Radical Resection of Pancreatic Neuroendocrine Tumors with Liver Mets Often Prolongs Survival

Poorly differentiated pancreatic neuroendocrine carcinoma (PNEC) grade 3 tumors demonstrate lower survival after radical resection of PNETs.

NANETS: Lymph Node Ratio Predicts Survival in Patients with Gastrointestinal (GI) Carcinoid Neuroendocrine Tumors

NANETS: Lymph Node Ratio Predicts Survival in Patients with Gastrointestinal (GI) Carcinoid Neuroendocrine Tumors

Lymph node ratio (LNR) may offer better survival prediction over the current measure for patients with carcinoid neuroendocrine tumors.

Some Locally-Advanced and Metastatic Pulmonary Carcinoid Tumors Respond to Chemotherapy

Some Locally-Advanced and Metastatic Pulmonary Carcinoid Tumors Respond to Chemotherapy

Octreotide has demonstrated promising results vs. a subset of carcinoid tumors, despite a lower overall response rate.

Gene Panel Identifies Primary Tumor Sites in Metastatic Neuroendocrine Tumors

Gene Panel Identifies Primary Tumor Sites in Metastatic Neuroendocrine Tumors

A 3-marker immunohistochemistry panel helps determine the primary site of malignancy in metastatic neuroendocrine tumors.

Tumor-Specific Mutations More Common in High-Grade Neuroendocrine Tumors

Tumor-Specific Mutations More Common in High-Grade Neuroendocrine Tumors

Tumor-specific mutations are common in high-grade neuroendocrine tumors.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs